Renaissance Capital logo

NSRX News

US IPO Weekly Recap: Bullish and Miami International complete the last major IPOs of the summer

BLSH

Eight issuers listed in the US this past week, six of which were eligible for inclusion in our IPO stats, joined by two SPACs. Seven IPOs and eight SPACS submitted initial filings. Crypto exchange Bullish (BLSH) priced above the upwardly revised...read more

Israeli biotech Nasus Pharma prices US IPO at the $8 low end

Nasus Pharma logo

Nasus Pharma, a Phase 2 biotech developing an intranasal powder for severe allergies and anaphylaxis, raised $10 million by offering 1.3 million shares at $8, the low end of the range of $8 to $10. Nasus Pharma is focused primarily on the development of...read more

Israeli biotech Nasus Pharma revises terms ahead of $11 million US IPO

Nasus Pharma logo

Nasus Pharma, a Phase 2 biotech developing an intranasal powder for severe allergies and anaphylaxis, revised the terms for its upcoming IPO on Monday. The Tel Aviv, Israel-based company now plans to raise $11 million by offering 1.25 million shares at a price ...read more

US IPO Weekly Recap: 6 small listings hit market as sizable IPOs join the pipeline

TLIH

Six IPOs and one SPAC debuted this week. Nine IPOs and two SPACs submitted initial filings this week. Singapore-based heavy equipment provider Ten-League International Holdings (TLIH) priced its US IPO at the bottom of the range to raise $9 million at a...read more